Recently, vascular endothelial growth factor (VEGF) has been recognized as an important mediator of immune suppression, and VEGF blockade may be effective in the antitumor immune response in addition to its direct effects on tumor vasculature. This evidence concerns the gene VEGFA and neoplasm.